Abstract
The plasma membrane transporters for dopamine (DAT), norepinephrine (NET), and serotonin (SERT) are the main sites of action for therapeutic and abused stimulant drugs. As a means to identify novel medications for stimulant addiction and other psychiatric disorders, we developed in vitro assays in rat brain tissue that can be used to determine structure–activity relationships for test compounds at these monoamine transporters. Uptake inhibition assays measure the ability of drugs to block the transporter-mediated uptake of [3H]neurotransmitters into synaptosomes, whereas release assays measure the ability of drugs to serve as transporter substrates that evoke efflux (i.e., release) of [3H]neurotransmitters from synaptosomes by reverse transport. These assays can be used to rapidly determine the potency of test compounds at DAT, NET, and SERT under similar conditions, establishing the selectivity of drugs across all three transporters. The combined results from uptake and release assays can discriminate whether a compound is a transporter inhibitor or substrate (i.e., releaser). Our assay procedures have been used to characterize the molecular mechanism of action for older amphetamine-type medications and newer transporter ligands with therapeutic potential. The data from these assays can also predict the addictive and neurotoxic properties of abused stimulants. Information provided by these assays continues to provide insight into monoamine transporter structure and function.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Gorman JM, Kent JM (1999) SSRIs and SMRIs: broad spectrum of efficacy beyond major depression. J Clin Psychiatry 60(Suppl 4):33–38
Iversen L (2006) Neurotransmitter transporters and their impact on the development of psychopharmacology. Br J Pharmacol 147(Suppl 1):S82–S88
Rothman RB et al (2001) Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39:32–41
Howell LL, Kimmel HL (2008) Monoamine transporters and psychostimulant addiction. Biochem Pharmacol 75:196–217
Rothman RB, Baumann MH (2003) Monoamine transporters and psychostimulant drugs. Eur J Pharmacol 479:23–40
Sitte HH, Freissmuth M (2015) Amphetamines, new psychoactive drugs and the monoamine transporter cycle. Trends Pharmacol Sci 36:41–50
Baumann MH, Wang X, Rothman RB (2007) 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. Psychopharmacology (Berl) 189:407–424
Fleckenstein AE et al (2007) New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 47:681–698
Gray EG, Whittaker VP (1962) The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. J Anat 96:79–88
Wilhelm BG et al (2014) Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins. Science 344:1023–1027
Rothman RB et al (1993) Identification of a GBR12935 homolog, LR1111, which is over 4,000-fold selective for the dopamine transporter, relative to serotonin and norepinephrine transporters. Synapse 14:34–39
Rothman RB et al (2015) Studies of the biogenic amine transporters 15. Identification of novel allosteric dopamine transporter ligands with nanomolar potency. J Pharmacol Exp Ther 353(3):529–538
Rothman RB et al (2000) Methamphetamine dependence: medication development efforts based on the dual deficit model of stimulant addiction. Ann N Y Acad Sci 914:71–81
Baumann MH et al (2013) Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive ‘bath salts’ products. Neuropsychopharmacology 38(4):552–562
Rudnick G, Clark J (1993) From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters. Biochim Biophys Acta 1144:249–263
Rothman RB, Baumann MH (2006) Therapeutic potential of monoamine transporter substrates. Curr Top Med Chem 6:1845–1859
Rothman RB et al (2003) In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates. J Pharmacol Exp Ther 307:138–145
Scholze P et al (2000) Transporter-mediated release: a superfusion study on human embryonic kidney cells stably expressing the human serotonin transporter. J Pharmacol Exp Ther 293:870–878
Rothman RB et al (2003) (+)-Fenfluramine and its major metabolite, (+)-norfenfluramine, are potent substrates for norepinephrine transporters. J Pharmacol Exp Ther 305:1191–1199
Yu H et al (2000) Uptake and release effects of diethylpropion and its metabolites with biogenic amine transporters. Bioorg Med Chem 8:2689–2692
Rothman RB et al (2012) Studies of the biogenic amine transporters. 14. Identification of low-efficacy “partial” substrates for the biogenic amine transporters. J Pharmacol Exp Ther 341(1):251–262
Baumann MH et al (2012) The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in the brain. Neuropsychopharmacology 37(5):1192–1203
Saha K et al (2015) ‘Second-generation’ mephedrone analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter function. Neuropsychopharmacology 40(6):1321–1331
Marusich JA et al (2014) Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology 87:206–213
Bonano JS et al (2015) Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues. Br J Pharmacol 172(10):2433–2444
Sakloth F et al (2015) Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues. Br J Pharmacol 172(9):2210–2218
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Partilla, J.S., Baumann, M.H., Decker, A.M., Blough, B.E., Rothman, R.B. (2016). Interrogating the Activity of Ligands at Monoamine Transporters in Rat Brain Synaptosomes. In: Bönisch, H., Sitte, H. (eds) Neurotransmitter Transporters. Neuromethods, vol 118. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3765-3_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3765-3_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3763-9
Online ISBN: 978-1-4939-3765-3
eBook Packages: Springer Protocols